Related Experiment Video
Updated: Sep 11, 2025
Procurement for a Vascularized and Reinnervated Abdominal Wall Allotransplantation
Published on: July 18, 2025
Every Body Has Value: Ending Discriminatory Restrictions on Anatomical Donations
Sara Gianella1, Jeff Taylor2, Brittany Shelton3
1Department of Medicine, University of California, San Diego, San Diego, California, USA.
Insights
Body donation programs should accept individuals with HIV and viral hepatitis. Modern safety protocols make exclusion based on outdated stigma scientifically unsound and ethically imperative.
Area of Science:
- Medical education
- Anatomical donation
- Public health
Background:
- Anatomical body donation is vital for medical training and research.
- Current US programs often exclude donors with HIV or viral hepatitis.
- These exclusions stem from historical stigma, not current scientific understanding.
Purpose of the Study:
- To advocate for revising body donor eligibility policies.
- To challenge outdated restrictions based on HIV and viral hepatitis status.
- To promote ethical and scientifically informed donation practices.
Main Methods:
- Reviewing current biosafety protocols and infectious disease transmission data.
- Examining examples from HIV research and organ transplantation.
- Analyzing the ethical implications of donor exclusion.
Main Results:
- Modern biosafety measures effectively mitigate risks associated with HIV and viral hepatitis.
- Excluding donors with these conditions is not supported by current scientific evidence.
- Revising policies aligns with advancements in infectious disease management.
Conclusions:
- It is scientifically sound and ethically imperative to include individuals with HIV and viral hepatitis in body donation programs.
- Outdated policies based on stigma should be replaced with evidence-based guidelines.
- Valuing all individuals through anatomical donation promotes dignity and scientific progress.
Abstract:
Anatomical body donation plays a critical role in medical education and scientific discovery. Yet, most programs in the United States continue to exclude individuals with human immunodeficiency virus (HIV) or viral hepatitis, despite modern biosafety protocols and decades of scientific progress. These outdated restrictions are rooted in historical stigma rather than current risk, and they unjustly deny people living with these conditions the opportunity to make a final, meaningful contribution to science. In this Viewpoint, we call for the urgent revision of donor eligibility policies to reflect contemporary understanding of infectious disease transmission and universal precautions. Drawing on examples from end-of-life HIV research and the broader transplant landscape, we argue that inclusion is both scientifically sound and ethically imperative. Every person deserves the dignity of being valued in death as in life, and no body should be excluded based on fear, misinformation, or outdated policy.
Related Concept Videos
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
01:28Kidney Transplant I: Introduction